Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

New urine test could detect womb cancer in three hours

February 3, 2021 Research and Development Cancer, urine test

A simple test using patented technology to detect the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) in urine could …
News
philippe_dro

Scenic Biotech appoints Dr Philippe Dro as Chairman

February 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …
Appointment
celgene_building

NICE recommends Celgene’s REVLIMID for multiple myeloma

January 27, 2021 Research and Development Cancer, Celgene

NICE has issued a Final Appraisal Document (FAD) recommending Celgene’s REVLIMID (lenalidomide) as maintenance treatment after an autologous stem cell …
News

Diurnal and Citrine sign licensing agreement for Alkindi

January 27, 2021 Research and Development Citrine, Diurnal

Diurnal Group has entered into an exclusive licence agreement for its product Alkindi (hydrocortisone granules in capsules for opening) with …
News
drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
Feature
nicki_grundy

Raremark appoints Nicki Grundy as CFO

January 20, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …
Appointment
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 20, 2021 Research and Development

The past week has seen promising developments in the race to find treatments for COVID-19; Jubilant and The Wistar Institute …
News
stem_cell

Scientists in Scotland make breakthrough MND discovery

January 20, 2021 Research and Development motor neurone disease

Researchers in Scotland have made a discovery that could reverse the damage caused by motor neurone disease (MND). University of …
News

NICE approves lipid disorder drug Myalepta for NHS use

January 20, 2021 Research and Development Amryt Pharma, NICE

NICE has approved Amryt’s rare lipid disorder drug Myalepta (metreleptin), currently the only leptin replacement therapy available, for use within …
News
astrazeneca_sign_sky

EU approves breast cancer drug Enhertu

January 20, 2021 Research and Development AstraZeneca, Daiichi Sankyo

The EU has granted AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) conditional approval as a monotherapy for the treatment of …
News

Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says

January 20, 2021 Research and Development COVID-19, Pfizer

The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …
News
landing-hero-images1

ViiV gets EU approval for children’s HIV treatment

January 13, 2021 Research and Development EU, HIV, ViiV

ViiV Healthcare, the global specialist HIV company, has received marketing authorisation from the European Commission for Tivicay (dolutegravir) 5mg dispersible …
News
turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021 Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …
News

Pfizer invests $25m in Vedanta BioSciences’ IBD treatment

January 13, 2021 Research and Development Pfizer, Vedanta Biosciences, inflammatory bowel disease

Pfizer has invested $25 million in Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases, …
News

Trial of potential new COVID-19 treatment begins in UK

January 13, 2021 Research and Development COVID-19, Synairgen, Vaccine

A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026